After-Hours Stock Movers 12/14: (GRTX) (CFVI) (DWAC) Higher; (LESL) (LEGN) (PK) Lower (more...)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Legend Biotech (LEGN) Prices 7.5M Share Offering at $40/sh
December 16, 2021 9:19 AM ESTLegend Biotech Corporation (NASDAQ: LEGN), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, today announced that it has priced an underwritten public offering of 7,500,000 American depositary shares (ADSs), each representing two ordinary shares, at a public offering price of $40.00 per ADS, for total gross proceeds of approximately $300.0 million. In addition, Legend Biotech has granted the underwriters a 30-day option to purchase up to an additional 1,125,000 ADSs at the public offering price, less underwriting discounts and commissions. All of the ADSs are being... More
Leslie's, Inc. (LESL) Prices 12.5M Share Offering
December 15, 2021 7:30 AM ESTLeslies, Inc. (the Company or Leslies) (Nasdaq: LESL) today announced the pricing of an underwritten public offering of 12,500,000 shares of common stock (the Offering) by certain of the Companys non-management stockholders (the Selling Stockholders). The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional 1,875,000 shares of common stock. The Selling Stockholders will receive all of the proceeds from the Offering. Leslies is not offering any shares of its common stock in the Offering and will not receive any proceeds from the Offering, including from any exercise by the... More
